Cancer-driven dynamics of immune cells in a microfluidic environment

Scientific Reports

Volumn 4, Issue , 2014, Pages

  Agliari, Elena ^a   Biselli, Elena ^a   De Ninno, Adele ^b   Schiavoni, Giovanna ^c   Gabriele, Lucia ^c   Gerardino, Anna ^d   Mattei, Fabrizio ^c   Barra, Adriano ^a   Businaro, Luca ^d  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^c ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^d IFN CNR   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON CONSENSUS SEQUENCE BINDING PROTEIN; INTERFERON REGULATORY FACTOR;

ANIMAL; CELL MOTION; COCULTURE; CYTOLOGY; EXPERIMENTAL MELANOMA; GENETICS; HUMAN; KNOCKOUT MOUSE; LEUKOCYTE; METABOLISM; MOUSE; PATHOLOGY; SPLEEN; SPLEEN TUMOR;

ANIMALS; CELL MOVEMENT; COCULTURE TECHNIQUES; HUMANS; INTERFERON REGULATORY FACTORS; LEUKOCYTES; MELANOMA, EXPERIMENTAL; MICE; MICE, KNOCKOUT; SPLEEN; SPLENIC NEOPLASMS;

EID: 84923828979     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep06639     Document Type: Article

References (39)

1. Kim, P. S., Levy, D. &Lee, P. P. Modeling and simulation of the immune system as a self-regulating network. Method. enzymol. 144, 79-109 (2009).
2. Wlodkowic, D., Faley, S., Zagnoni, M., Wikswo, J. P. & Cooper, J. M. Microfluidic single-cell array cytometry for the analysis of tumor apoptosis. Anal. Chem. 81, 5517-5523 (2009).
3. Chung, S., Sudo, R., Vickerman, V., Zervantonakis, I. K. & Kamm, R. D. Microfluidic platforms for studies of angiogenesis, cell migration, and cell-cell interactions. Ann. Biomed. Eng. 38, 1164-1177 (2010).
4. Mora, T. et al. Maximum entropy models for antibody diversity. Proc. Natl. Acad. Sci. USA 107, 5405-5410 (2010).
5. Agliari, E., Annibale, A., Barra, A., Coolen, A. C. C. & Tantari, D. Immune networks: Multitasking capabilities at medium load. J. Phys. A 46, 335101s (2013).
6. Agliari, E., Annibale, A., Barra, A., Coolen, A. C. C. & Tantari, D. Immune networks: Multitasking capabilities near saturation. J. Phys. A 46, 415003 (2013).
7. Martelli, C. et al. Identifying essential genes in Escherichia coli from a metabolic optimization principle. Proc. Natl. Acad. Sci. USA 106, 2607-2611 (2009).
8. Annibale, A. & Coolen, A. C. C. Protein Networks Reveal Detection Bias and Species Consistency When Analysed by Information-Theoretic Methods. PLoS-One e12083 (2010).
9. Agliari, E., Asti, L., Barra, A., Scrivo, R., Valesini, G. & Wallis, R. S. Application of a stochastic modeling to assess the evolution of tuberculous and non-tuberculous mycobacterial infection in patients treated with tumor necrosis factor inhibitors. PLoS One e55017 (2012).
10. Perelson, A. S. & Weisbuch, G. Immunology for physicists. Rev. Mod. Phys. 69, 1219 (1997).
11. Galper, T., Marre, O., Amodei, D., Schneidman, E., Bialek, W., Berry, I. I. & Michael, J. Searching for collective behavior in a network of real neurons. preprint arXiv1306-3061 (2013).
12. Agliari, E., Barra, A., Moauro, F. & Guerra, F. A thermodynamic perspective of immune capabilities. J. Theor. Biol. 287, 48-63 (2011).
13. Vedel, S. et al. Migration of cells in a social context. Proc. Natl. Acad. Sci. USA 110, 129-134 (2013).
14. Boral, D. & Nie, D. Cancer stem cells and niche mircoenvironments. Biomed. microdevices 4, 2502-2514 (2012).
15. Dvorak, H.F., Weaver, V.M., Tlsty, T.D. &Bergers, G. Tumor microenvironment and progression. J. Surg. Oncol. 103, 468-474 (2012).
16. Hodi, F. S. & Dranoff, G. The biologic importance of tumor-infiltrating lymphocytes. J. Cutan. Pathol. 37, 48-53 (2010).
17. Kerkar, S. P. & Restifo, N. P. Cellular constituents of immune escape within the tumor microenvironment. Cancer Res.72, 3125-3130 (2012).
18. Lu, T. & Gabrilovich, D. I. Molecular pathways: tumor-infiltrating myeloid cells and reactive oxygen species in regulation of tumor microenvironment. Clin Cancer Res.18, 4877-4882 (2012).
19. Ma, Y., Aymeric, L., Locher, C., Kroemer, G. & Zitvogel, L. The dendritic celltumor cross-talk in cancer. Curr. Opin. Immunol. 38, 47-52 (2012).
20. Schiavoni, G., Gabriele, L. & Mattei, F. The tumor microenvironment: a pitch for multiple players. Front. Oncol. 3, 74-92 (2013).
21. Toh, B., Chew, V., Dai, X., Khoo, K., Tham, M., Wai, L. E., Hubert, S., Velumani, S., Zhi, L. & Huang, C. Immune predictors of cancer progression. Immunol. Res. 53, 229-234 (2012).
22. Mattei, F., Schiavoni, G., Sestili, P., Spadaro, F., Fragale, A., Sistigu, A., Lucarini, V., Spada, M., Sanchez, M., Scala, S., Battistini, A., Belardelli, F. & Gabriele, L. IRF-8 controls melanoma progression by regulating the cross talk between cancer and immune cells within the tumor microenvironment. Neoplasia 14, 1223-1235 (2012).
23. Mattei, F. et al. A multidisciplinary study using in vivo tumor models and microfluidic cell-on-chip approach to explore the cross-talk between cancer and immune cells. J. Immunotoxic. 3, 42354 (2014).
24. Hanahan, D. & Weinberg, R. A. The hallmarks of cancer. Cell 100, 57-70 (2000).
25. Businaro, L., and Ninno, A. D., Schiavoni, G., Lucarini, V., Ciasca, G., Gerardino, A., Belardelli, F., Gabriele, L. & Mattei, F. Cross talk between cancer and immune cells: exploring complex dynamics in a microfluidic environment. Lab Chip 13, 229-239 (2013).
26. Giese, N. A., Gabriele, L., Doherty, T. M., and Klinman, D. M., Tadesse-Heath, L., Contursi, C., Epstein, S. L. & Morse, H. C. Interferon (IFN) consensus sequence-binding protein, a transcription factor of the IFN regulatory factor family, regulates immune responses in vivo through control of interleukin 12 expression. J. Exp. Med. 186, 1535-1546 (1997).
27. Schiavoni, G., Mattei, F., Sestili, P., Borghi, P., Venditti, M., Morse, H. C., Belardelli, F. & Gabriele, L. ICSBP is essential for the development of mouse type I interferon-producing cells and for the generation and activation of CD8a1 dendritic cells. J. Exp. Med. 196, 1415-1425 (2002).
28. 1 integrin alters epithelial cell phenotype, proliferation and haptotaxis. J Cell Sci 117 (2004).
29. Yao, E. et al. Suppression of HER2/HER3-Mediated Growth of Breast Cancer Cells with Combinations of GDC-0941 PI3K Inhibitor, Trastuzumab, and Pertuzumab. Clin Cancer Res 15, 4147 (2009).
30. a1 dendritic cells. Blood 101, 305-310 (2003).
31. Mattei, F., Schiavoni, G., Borghi, P., Venditti, M., Canini, I., Sestili, P., Pietraforte, I., and Morse, H. C., Ramoni, C. & Belardelli, F. ICSBP/IRF-8 differentially regulates antigen uptake during dendritic-cell development and affects antigen presentation to CD41 T cells. Blood 108, 609-617 (2006).
32. Schiavoni, G., Gabriele, L. & Mattei, F. The dual role of IRF8 in cancer immunosurveillance. Oncoimmunology e25476 (2013).
33. Schiavoni, G., Mattei, F., Borghi, P., Sestili, P., Venditti, M., Morse, H. C., Belardelli, F. & Gabriele, L. ICSBP is critically involved in the normal development and trafficking of Langerhans cells and dermal dendritic cells. Blood 6, 2221-2228 (2004).
34. Weiss, G. H. Aspects and applications of random walks, (North-Holl. Press, Amsterdam, 1994).
35. Batschelet, E. Circular statistics in biology, (Academic Press Inc., London, 1981).
36. Almeida, P. J. A. L., Vieira, M. V., Kajin, M., Forero-Medina, G. & Cerqueira, R. Indices of movement behavior: conceptual background, effects of scale and location errors. Zoologia 5, 674-680 (2010).
37. Klafter, J. & Sokolov, I. M. First Steps in Random Walks: From Tools to Applications, (Oxford Univ. Press, Oxford, 2011).
38. Barkai, E., Garini, Y. & Metzler, R. Strange kinetics of single molecules in living cells. Phys. Today 65, 29-35 (2012).
39. Yang, T. D., Park, J., Choi, Y., Choi, W., Ko, T. & Lee, K. J. Zigzag turning preference of freely crawling cells. PLoS-One e20255 (2011).